Literature DB >> 32266732

Using, risking, and consent: Why risking harm to bystanders is morally different from risking harm to research subjects.

Alec Walen1.   

Abstract

Subjects in studies on humans are used as a means of conducting the research and achieving whatever good would justify putting them at risk. Accordingly, consent must normally be obtained before subjects are exposed to any substantial risks to their welfare. Bystanders are also often put at risk, but they are not used as a means. Accordingly-or so I argue-consent is more often unnecessary before bystanders are exposed to similar substantial risks to their welfare.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  Means principle; bystanders; human subjects research; informed consent; research ethics; risk

Year:  2020        PMID: 32266732      PMCID: PMC7541549          DOI: 10.1111/bioe.12743

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  7 in total

1.  Respect for persons, informed consent and the assessment of infectious disease risks in xenotransplantation.

Authors:  J H Barker; L Polcrack
Journal:  Med Health Care Philos       Date:  2001

2.  Does informed consent to research require comprehension?

Authors:  Gopal Sreenivasan
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

3.  Informed consent in therapy and experimentation.

Authors:  A Donagan
Journal:  J Med Philos       Date:  1977-12

4.  Protecting third parties in human subjects research.

Authors:  David B Resnik; Richard R Sharp
Journal:  IRB       Date:  2006 Jul-Aug

5.  Missing the forest: further thoughts on the ethics of bystander risk in medical research.

Authors:  Jonathan Kimmelman
Journal:  Camb Q Healthc Ethics       Date:  2007       Impact factor: 1.284

6.  Third-party risks in research: should IRBs address them?

Authors:  Daniel M Hausman
Journal:  IRB       Date:  2007 May-Jun

7.  The ethics of biosafety considerations in gain-of-function research resulting in the creation of potential pandemic pathogens.

Authors:  Nicholas Greig Evans; Marc Lipsitch; Meira Levinson
Journal:  J Med Ethics       Date:  2015-08-28       Impact factor: 2.903

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.